Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001437749-23-008896 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 2023-03-29 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $20.62 | -741 | 270.4K | -0.3% | -$15.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-29 | S | D | 741 | $20.62 | 270,445 | D | — | — |